Dermatologists detect more cancers during full-body exams

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 9
Volume 18
Issue 9

Most melanomas are found during complete skin exams of patients who came to see a physician for different complaints, according to a study in the Archives of Dermatology.

Most melanomas are found during complete skin exams of patients who came to see a physician for different complaints, according to a study in the Archives of Dermatology.

Physician-detected cancers are also thinner and more likely to be only on the outer layer of skin than cancers detected by patients (Arch Dermatol 145:873-876, 2009).

Researchers at North Florida Dermatology Associates in Jacksonville found 60% of melanomas on the outer layer of the skin were detected by the dermatologist and were not among the reasons the patient came into the clinic.

Out of 126 cases of melanoma, 51 were invasive and 75 were on the outer layer of skin. The dermatologists found melanomas with a median depth of 0.33 mm vs 0.55 mm for the melanomas found by patients.

The data suggested full-body skin exams by a dermatologist would benefit individual patients and lessen the financial impact of melanoma, according to Jonathan Kantor, MD, and Deborah E. Kantor, MSN, the authors of the retrospective analysis.

Recent Videos
Data from the SPOTLIGHT and GLOW trials reveal that zolbetuximab increased survival in patients with CLDN18.2-positive gastric or GEJ adenocarcinoma.
The incorporation of zolbetuximab in addition to chemotherapy has shown benefit in patients with Claudin 18.2–positive gastric cancers in clinical trials.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Patrick Oh, MD, highlights next steps for further research in treating patients with systemic therapy in addition to radiotherapy for early-stage NSCLC.
The ability of metformin to disrupt mitochondrial metabolism may help mitigate the risk of cancer in patients with Li-Fraumeni syndrome.
Related Content